Avinger, Inc. (AVGR) financial statements (2021 and earlier)

Company profile

Business Address 400 CHESAPEAKE DRIVE
REDWOOD CITY, CA 94063
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments11141517161010
Cash and cash equivalents11141517161010
Receivables1111112
Inventory, net of allowances, customer advances and progress billings4444334
Inventory4444334
Prepaid expense 00    
Other undisclosed current assets0012111
Total current assets:17202124221617
Noncurrent Assets
Operating lease, right-of-use asset556 
Property, plant and equipment2222222
Other noncurrent assets110  11
Total noncurrent assets:7882233
TOTAL ASSETS:24282926241819
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3554765
Accounts payable1111121
Accrued liabilities1111111
Employee-related liabilities2111111
Interest and dividends payable 321321
Debt10999788
Total current liabilities:13151413141412
Noncurrent Liabilities
Long-term debt and lease obligation445    
Operating lease, liability445 
Liabilities, other than long-term debt0000000
Other liabilities0000000
Total noncurrent liabilities:4450000
Total liabilities:17191913141413
Stockholders' equity
Stockholders' equity attributable to parent791013947
Common stock0000000
Additional paid in capital355352349347338327324
Accumulated deficit(348)(343)(339)(334)(329)(323)(317)
Total stockholders' equity:791013947
TOTAL LIABILITIES AND EQUITY:24282926241819

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues3222222
Cost of revenue(2)(2)(2)(1)(1)(1)(2)
Cost of goods and services sold(0)  (0)(0)  
Gross profit:111011(0)
Operating expenses(6)(5)(5)(5)(6)(6)(5)
Operating loss:(5)(5)(5)(5)(6)(5)(5)
Nonoperating income0000000
Investment income, nonoperating 000 00
Other nonoperating income (expense) 000 0(0)
Interest and debt expense(0)(0)(0)(0)(0)(0)(0)
Loss before gain (loss) on sale of properties:(5)(5)(5)(5)(6)(5)(6)
Other undisclosed net income (loss)(0)   0  
Net loss attributable to parent:(5)(5)(5)(5)(6)(5)(6)
Preferred stock dividends and other adjustments(1)(1)(1)(1)(1)(1)(1)
Net loss available to common stockholders, diluted:(6)(6)(6)(6)(7)(6)(7)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(5)(5)(5)(5)(6)(5)(6)
Comprehensive loss, net of tax, attributable to parent:(5)(5)(5)(5)(6)(5)(6)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: